Awareness of Nucleic Acid-Based Therapies

October 25, 2019

Dr. Melissa Moore, global messenger RNA (mRNA) expert and chief scientific officer of Moderna’s mRNA research platform, joins Dr. Diane Hayes, InCrowd co-founder and board member, for Exploring What Physicians Know and Don’t Know About Nucleic Acid-Based Medicines, a webinar examining the emerging therapy area, medications in the field, and analysis of recent InCrowd prescriber research.

Key learnings:


  • A high-level understanding of the emerging class of therapeutics based on molecular biology approaches to altering gene expression by targeting nucleic acids (DNA and RNA)
  • Prescriber awareness of nucleic acid-based medicines
  • Insight across a variety of specialists from academic medical centers, as well as other practice settings
  • Prescriber perceptions of the potential impact of nucleic acid-based medicines
Who should watch:


  • Anyone interested in nucleic acid-based medicines
  • Healthcare and life science marketers, market insights, research, new business, and commercialization professionals
  • Healthcare and hospital administrators
  • Physicians and biologists interested or involved in nucleic acid-based medicines
  • Payors
  • Pharmacists
  • Those interested in therapeutic innovation

  • This field is for validation purposes and should be left unchanged.